職稱
- 核子醫學科正子造影中心主任
- 核子醫學科主治醫師
學歷
- 慈濟大學醫學系畢業
經歷
- 佛教慈濟醫療財團法人花蓮慈濟醫院核子醫學科 住院醫師
- 佛教慈濟醫療財團法人花蓮慈濟醫院核子醫學科 總醫師
- 佛教慈濟醫療財團法人花蓮慈濟醫院核子醫學科 臨床研究醫師
專長：
- 核子醫學
- 正子造影
- DXA判讀
現職
- 佛教慈濟醫療財團法人花蓮慈濟醫院核子醫學科主治醫師
- 教育部部定助理教授
專科證書
- 核子醫學專科醫師證書
專科學會
- 中華民國核醫學學會
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- 中華民國骨質疏鬆症醫學會
獲獎及其他榮譽
- 2011 年度臺灣醫學會杜聰明優秀畢業成績獎
- 2011 年台灣神經脊椎外科醫學會年會大會優秀論文獎
- 2018年台灣核子醫學年會學術壁報競賽第二名
- 2019年Annual Meeting of Society of Nuclear Medicine and Molecular Imaging學術壁報競賽Award candidate
- 慈濟醫療財團法人花蓮慈濟醫院2019年年度花蓮院區個人(年輕主治醫師)最佳研究成果獎第二名
- 慈濟醫療財團法人花蓮慈濟醫院2020年年度花蓮院區個人(年輕主治醫師)最佳研究成果獎第三名
- 慈濟醫療財團法人花蓮慈濟醫院2021年年度花蓮院區個人(年輕主治醫師)最佳研究成果獎第二名
期刊論文
1. Lue KH, Chen YH*, Chu SC, Chang BS, Lin CB, Chen YC, Lin HH, Liu SH. A comparison of 18F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study. Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001776. Epub ahead of print.
2. Chen YH, Lue KH, Lin CB, Chen KC, Chan SC, Chu SC*, Chang BS, Chen YC. Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer. Int J Mol Sci. 2023 Feb 16;24(4):3988.
3. Lue KH*, Chen YH, Wu YF, Liu SH. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma. Nucl Med Commun. 2023 Jan 1;44(1):74-80.
4. Chen YH*, Lue KH, Chu SC, Chang BS, Lin CB. The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease. Nucl Med Commun. 2023 Jan 1;44(1):100-107.
5. Chen YH, Chen YC, Lue KH*, Chu SC*, Chang BS, Wang LY, Li MH, Lin CB. Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma. Ann Nucl Med. 2023 Feb;37(2):139-150.
6. Lue KH, Chu SC, Wang LY, Chen YC, Li MH, Chang BS, Chan SC, Chen YH*, Lin CB, Liu SH. Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma. Ann Nucl Med. 2022 Mar;36(3):256-266.
7. Lue KH, Huang CH, Hsieh TC, Liu SH, Wu YH*, Chen YH*. Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy. Cancers. 2022, 14(2), 309.
8. Chen YH, Chu SC, Wang LY, Wang TF, Lue KH, Lin CB, Chang BS, Liu DW, Liu SH, Chan SC. Prognostic Value of Combing Primary Tumor and Nodal Glycolytic-Volumetric Parameters of 18F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis. Diagnostics (Basel). 2021 Jun 9;11(6):1065.
9. Lue KH, Wu YF, Lin HH, Hsieh TC, Liu SH, Chan SC, Chen YH*. Prognostic Value of Baseline Radiomic Features of 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma. Diagnostics (Basel). 2020 Dec 28;11(1):36.
10. Chen YH, Wang TF, Chu SC, Lin CB, Wang LY, Lue KH, Liu SH, Chan SC. Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. PLoS One. 2020 Dec 28;15(12):e0244502.
11. Chen YH, Chen HT, Lee MC, et al. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound. Ann Nucl Med. 2020;34(8):527-537.
12. Kun-Han Lue, Yi-Feng Wu, Shu-Hsin Liu, Tsung-Cheng Hsieh, Keh-Shih Chuang, Hsin-Hon Lin*, Chen YH*. Intratumour heterogeneity assessed by 18F-FDG PET/CT predicts treatment response and survival outcomes in patients with Hodgkin lymphoma. Acad Radiol. 2020;27(8):e183-e192.
13. Chen YH, Hsu YH, Chen HT, Chang BS, Liu SH. Metastatic Parathyroid Hormone-Secreting Prostate Adenocarcinoma Mimicking Ectopic Parathyroid Adenoma Demonstrated on 99mTc-MIBI Image. Clin Nucl Med. 2020;45(7):555-556.
14. Chen YH, Ching-Jung Chen, Ling-Yi Wang, Kun-Han Lue, Ching-Lin Sung, Shu-Hsin Liu. A comparison of different attenuation correction methods for calculating semiquantitative parameters of TRODAT-1 SPECT. Ann Nucl Med Mol Im. 2019;32:63-74.
15. Kun-Han Lue, Yi-Feng Wu, Shu-Hsin Liu, Tsung-Cheng Hsieh, Keh-Shih Chuang, Hsin-Hon Lin*, Chen YH*. Prognostic Value of Pretreatment Radiomic Features of F-18 FDG PET in Patients With Hodgkin Lymphoma. Clinical Nuclear Medicine 2019 Oct;44(10):e559-e565.
16. Chen YH, Kun-Han Lue, Sung-Chao Chu, Bee-Song Chang, Ling-Yi Wang, Dai-Wei Liu, Shu-Hsin Liu, Yin-Kai Chao, Sheng-Chieh Chan*. Combining the radiomic features and traditional parameters of 18F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. Ann Nucl Med. 2019 Sep;33(9):657-670.
17. Chen YH, Chang KP, Chu SC, Yen TC, Wang LY, Chang JT, Hsu CL, Ng SH, Liu SH, Chan SC. Value of early evaluation of treatment response using (18)F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):650-660.
18. Ching-Chun Ho, Chen YH *, Shu-Hsin Liu, Hwa-Tsung Chen, Ming-Che Lee. The optimal imaging time of Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer. Tzu Chi Medical Journal. 2019;31(3):163-168.
19. Chen YH, Hann-Chorng Kuo, Chih-Hao Kao, Jing-Liang Chen, Shu-Hsin Liu. F-18 Fluorocholine PET/CT in the biochemically relapsed prostate cancer patients: is it sensitive enough for early disease detection? Ann Nucl Med Mol Im. 2018;31:1-11.
20. Yan-Jyun Chen, Chia-Yi Lee, Ching-Lin Sung, Shu-Hsin Liu, Chen YH*. Incidental meningioma detected on Tc-99m MDP bone scintigraphy in a patient with colorectal cancer. Ann Nucl Med Mol Im. 2018;31:98-102.
21. Chen YH, Jen-Hung Wang, Shu-Hsin Liu, Ji-Hung Wang. The First Experience on the Appropriate Use Analysis of Radionuclide Myocardial Perfusion Imaging in Taiwan. Ann Nucl Med Mol Im. 2017;30:109-117.
22. Chen YH, Raymond Y. Lo. Alzheimer’s disease and osteoporosis. Tzu Chi Medical Journal 2017 Jul-Sep;29(3):138-142.
23. Chen YH, Ching-Lin Sung, Jing-Liang Chen, Shu-Hsin Liu. Early Post-Voiding F-18 Fluorocholine PET/CT Improves Detection of Residual Prostate Adenocarcinoma in the Prostate Bed After Prostatectomy. Ann Nucl Med Mol Im. 2017;30:77-81.
24. Chen YH, Yung-Hsiang Hsu, Yen-Chen Chen, Shu-Hsin Liu. Incidental Gastric Gastrointestinal Stromal Tumor Detected By Radionuclide Bone Imaging. Ann Nucl Med Mol Im. 2017;30:72-76.
25. Chen YH, LiuSH. Abnormal Bone Tracer Uptake in Urinary Tract Calculi：Report a Series of Four Cases. Ann Nucl Med Mol Im. 2016;29(2):78-83.
26. Chen YH, Wang JH, Liu SH, Wang JH. Demographic Analysis of Dipyridamole Induced Adverse Reaction in Patients Receiving Myocardial Perfusion Scans in Taiwan. Annals of Nuclear Medicine and Molecular Imaging 2014;27:122-130.
27. Chen YH, Liu SH, Lan WC. Tc-99m Phytate Peritoneoscintigraphy for Hepatic Hydrothorax. Ann Nucl Med Mol Im. 2013 Oct;26(3):97-8.
28. Chen YH, Hsieh HJ. Single photon emission computed tomography/computed tomography for malignant otitis externa: lesion not shown on planar image. Am J Otolaryngol. 2013 Mar-Apr;34(2):169-71.
